Home > Insider Trading > Filing (0000899243-21-019685)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1680367	Shattuck Labs Inc.	STTK	Pharmaceutical Preparations (2834)	812575858

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1827315	Josiah Hornblower	C/O Shattuck Labs, Inc. 500 W. 5Th Street, Suite 1200 Austin TX 78701		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-13	10,090	$25.88	3,264,295	No	4	S	Indirect	By Hornblower Capital Holdings, LLC
Common Stock	Disposition	2021-05-14	11,095	$26.24	3,253,200	No	4	S	Indirect	By Hornblower Capital Holdings, LLC
Common Stock	Disposition	2021-05-17	6,336	$26.30	3,246,864	No	4	S	Indirect	By Hornblower Capital Holdings, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Hornblower Capital Holdings, LLC
No	4	S	Indirect	By Hornblower Capital Holdings, LLC
No	4	S	Indirect	By Hornblower Capital Holdings, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	79,356	Indirect	By Stone Dock Investors

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $24.475 to $27.86. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.09 to $27.87. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.455 to $26.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.